Evidence map›Paper›PMID 31476478›Full record

ArticlePapillomavirus research (Amsterdam, Netherlands)2019

The role of healthcare providers in HPV vaccination programs - A meeting report.

Alex Vorsters, Paolo Bonanni, Helena C Maltezou, Joanne Yarwood, Noel T Brewer, F Xavier Bosch, Sharon Hanley, Ross Cameron, Eduardo L Franco, Marc Arbyn and 6 more

Open access · goldAbstract readConference Proceedings
In one paragraph

Article in Papillomavirus research (Amsterdam, Netherlands), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 6 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 6 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Implementing single-dose HPV vaccination in Canada.Human vaccines & immunotherapeutics · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 13 institutions in 10 countries.

Alex VorstersCentre for the Evaluation of Vaccination, University of Antwerp, Belgium. Electronic address: alex.vorsters@uantwerpen.be.
Paolo BonanniUniversity of Florence, Health Sciences, Florence, Italy.
Helena C MaltezouDepartment for Interventions in Healthcare Facilities, Hellenic Center for Disease Control and Prevention, Athens, Greece.
Joanne YarwoodImmunisation and Countermeasures Division, National Infection Service, Public Health England, London, UK.
Noel T BrewerDepartment of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, United States.
F Xavier BoschCancer Epidemiology Research Program, IDIBELL, Catalan Institute of Oncology, L'Hospitalet De Llobregat, Barcelona, Spain.
Sharon HanleyDepartment of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Ross CameronNHS National Health Services Scotland, Health Protection Scotland, Glasgow, UK.
Eduardo L FrancoDepartment of Oncology, McGill University, Montreal, Canada.
Marc ArbynUnit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium.
Nubia MuñozEmeritus Professor at the Cancer Institute of Colombia, Colombia.
Mira KojouharovaNational Centre of Infectious and Parasitic Diseases, Sofia, Bulgaria.
Jade PattynCentre for the Evaluation of Vaccination, University of Antwerp, Belgium.
Marc BaayP95, Epidemiology and Pharmacovigilance, Leuven, Belgium.
Emilie KarafillakisVaccine Confidence Project, London School of Hygiene & Tropical Medicine, London, UK.
Pierre Van DammeCentre for the Evaluation of Vaccination, University of Antwerp, Belgium.
University of Antwerp · BEHealth Protection Scotland · GBHellenic Center for Disease Control & Prevention · GRHokkaido University · JPInstitut d'Investigació Biomédica de Bellvitge · ESInstituto Nacional de Cancerología · COInstitut Scientifique de Santé Publique · BELondon School of Hygiene & Tropical Medicine · GBMcGill University · CANational Center of Infectious and Parasitic Diseases · BGPublic Health England · GBUniversity of Florence · ITUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Human Papillomavirus (HPV) Prevention and Control Board convened a meeting in Bucharest, Romania (May 2018), to discuss the role of healthcare providers (HCPs) in prevention programs, with a focus on HPV vaccination and cervical cancer screening. International and local experts discussed the role that HCPs can play to increase the uptake of HPV vaccine and screening. Experts recommended: 1) increasing HCP norms of getting vaccinated; 2) training providers to make effective recommendations; 3) making culturally appropriate materials available, in local languages; and 4) centralizing and coordinating education and information material, to direct both HCPs and the general public to the best material available.

Indexed as

Health PersonnelEuropeHealth Knowledge, Attitudes, PracticeHealth Plan ImplementationHumansPapillomaviridaePapillomavirus InfectionsPapillomavirus VaccinesPreventive Health ServicesPublic Health SurveillanceVaccinationPapillomavirus Vaccines

Identifiers

PMID31476478
PMCPMC7268105
OpenAlexW2971299524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.